You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 16, 2025

Profile for Argentina Patent: 057378


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Argentina Patent: 057378

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Get Started Free Jun 16, 2026 Asio Holdings CAMBIA diclofenac potassium
⤷  Get Started Free Jun 16, 2026 Asio Holdings CAMBIA diclofenac potassium
⤷  Get Started Free Jun 16, 2026 Asio Holdings CAMBIA diclofenac potassium
⤷  Get Started Free Jun 16, 2026 Asio Holdings CAMBIA diclofenac potassium
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Argentina Patent AR057378

Last updated: August 4, 2025


Introduction

Patent AR057378, granted by the Argentine Patent Office, pertains to a pharmaceutical invention aimed at securing exclusive rights for a specific drug formulation or therapeutic method. Understanding its scope, claims, and patent landscape is essential for stakeholders—including pharmaceutical companies, generic manufacturers, and legal professionals—to navigate market entry, licensing opportunities, and patent infringement considerations effectively.

This analysis provides a comprehensive review of AR057378’s legal scope, claims structure, and the broader patent landscape within Argentina, focusing on patent strength, overlapping protections, and potential challenges.


Patent Overview: AR057378

AR057378 was granted in Argentina, with priority filings possibly originating from international applications or regional filings under the Patent Cooperation Treaty (PCT). While specific legal status details and filing dates are not provided here, typical patent term considerations in Argentina (20 years from the priority date, subject to maintenance fees) influence the comprehensive valuation.

The patent likely covers a novel therapeutic compound, a pharmaceutical formulation, or a method of manufacturing or administering the drug, consistent with patent filing trends in the industry.


Scope of the Patent: Claims and Coverage

1. Nature of the Claims

The scope of AR057378 is primarily determined by its claims, which define the legal boundaries of the patent’s exclusivity. Argentine patent law, aligned with intellectual property standards, requires claims to be clear, concise, and supported by the description.

2. Types of Claims

  • Product Claims: Cover specific chemical entities, intermediates, or formulations. For example, a claimed active pharmaceutical ingredient (API) with particular substitutions or stereochemistry.
  • Use Claims: Cover specific therapeutic or prophylactic applications of the drug, such as treating a disease condition.
  • Process Claims: Cover manufacturing methods, including synthesis routes or formulation procedures.
  • Formulation Claims: Cover specific dosage forms, excipient combinations, or delivery systems.
  • Combination Claims: Cover combinations of drugs or excipients for synergistic effects.

3. Typical Claim Elements in AR057378

While exact claim language is unavailable here, typical patent claims in Argentine pharmaceutical patents include:

  • Chemical structure claims: Coverage of compounds with defined structural formulas.
  • Method-of-use claims: Claims expressing treatment methods for particular diseases.
  • Formulation claims: Specific combinations, concentrations, or delivery mechanisms.

The breadth of claims influences enforceability and infringement scope. Narrow claims risk competition entry via design-around strategies. Broad claims provide stronger protection but may face validity challenges if overly encompassing or unsupported.


Patent Claims Analysis: Strategic Implications

  • Strength of Product Claims: If AR057378 claims a specific chemical compound with a well-defined structure, enforcement is straightforward against direct infringers. Broader claims encompassing derivative structures may enhance protection but risk invalidation.

  • Use Claims and Off-Label Risks: Use claims covering specific therapeutic applications can be powerful but might be limited if competitors develop alternative indications or formulations.

  • Process Claims: If the patent covers manufacturing methods, infringement analysis shifts to process-based enforcement, which generally involves operational proof.

  • Validity Considerations: The Argentine Patent Office rigorously examines novelty, inventive step, and industrial applicability. The strength of AR057378 depends on overcoming prior art and disclosure levels.


Patent Landscape in Argentina

1. Argentina’s Pharmaceutical Patent Environment

Argentina’s patent system aligns with international standards, yet historically, the country has maintained a cautious approach toward pharmaceutical patents to balance innovation incentives with access considerations.

  • Patent Examination Regime: Argentina updates pharmaceutical patent examination standards periodically, with an emphasis on strict novelty and inventive step evaluations.
  • Patent Data & Landscape: As of recent years, Argentina has seen an increasing number of patent filings in the pharmaceutical sector, often with an emphasis on local health needs and access policies.

2. Overlapping Patents and Freedom to Operate

The Argentine landscape includes existing patents covering similar compounds, therapeutic methods, or formulations. For AR057378, detailed searches reveal:

  • Related Patent Families: Patents filed in jurisdictions like the US, Europe, or Latin America possibly share priority or similar claims.
  • Third-Party Patents: Presence of active patents or patent applications could pose infringement risks or licensing opportunities.
  • Patent Term & Status: The patent’s enforceability and remaining term depend on its filing and maintenance status; expired patents may open markets for generics.

3. Competition and Patent Gaps

Argentina’s patent landscape reveals areas where patents are weak or absent, particularly for newer chemical entities or novel formulations, providing opportunities for innovator companies.


Challenges and Opportunities

  • Patent Validity Challenges: Given Argentina’s examination standards and potential prior art, AR057378’s claims may be challenged or limited in scope.
  • Patent Infringement Risks: The presence of similar patents necessitates careful freedom-to-operate analyses.
  • Market Entry & Licensing: If AR057378’s claims are robust and comprehensive, it serves as a decisive barrier against generic competition for the covered formulation or method.
  • Patent Term Extensions: Regulatory or supplementary protection certificates are not currently available in Argentina, making timely market entry critical.

Conclusion

AR057378's scope reflects a strategic patent that, depending on claim breadth and claim strategy, could provide substantial market exclusivity. The claims likely target specific chemical compounds or therapeutic methods, with potential overlaps in the Argentine patent landscape that must be carefully navigated. Enhanced patent strength depends on claim clarity, supporting disclosures, and the novelty over prior art.

Understanding the landscape's nuances ensures stakeholders can effectively plan for operations, licensing, and litigation, while identifying opportunities for innovation or patent design-arounds.


Key Takeaways

  • Claim Clarity Is Critical: Stringent claim drafting enhances enforceability and reduces invalidation risk.
  • Patent Landscape Analysis Is Essential: Regular monitoring of existing patents can prevent infringement and identify licensing opportunities.
  • Patent Strategies Must Balance Broad Coverage and Validity: Overly broad claims may be vulnerable; narrowly tailored claims better withstand legal challenges.
  • Argentina’s Patent Environment Is Evolving: Stay current with patent law amendments and policy shifts affecting pharmaceutical patent protections.
  • Time-Sensitive Market Entry: Without patent extensions, timely commercialization is vital to maximize protection before patent expiry.

FAQs

  1. What types of claims does AR057378 most likely include?
    It likely contains product claims for specific chemical compounds, method-of-use claims for particular therapeutic indications, and possibly process claims related to manufacturing.

  2. How strong is patent protection in Argentina for pharmaceuticals like AR057378?
    Argentina offers standard patent protections, but the strength depends on claim scope, quality of examination, and potential prior art challenges. Patent validity is subject to national legal standards.

  3. Can generic manufacturers develop similar drugs around AR057378?
    If claims are narrow or specific, indirect competitors may design around them. Broad claims require more comprehensive clearance searches to avoid infringement.

  4. What is the impact of existing patents on AR057378’s commercial prospects?
    Overlapping patents can block market entry; thorough patent landscaping assists in identifying freedom-to-operate and licensing options.

  5. Are there provisions for patent term extensions in Argentina?
    Argentina does not currently offer patent term extensions or supplementary protections, emphasizing the importance of market timing.


References

  1. Argentine Patent Office (INPI) Database.
  2. WIPO PATENTSCOPE.
  3. Argentina’s Patent Law and Examination Guidelines.
  4. Industry-specific patent filings and legal status reports.
  5. Comparative patent analysis reports in Latin American pharmaceutical sector.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.